CD44 and triple-negative breast carcinoma: In the triple-negative breast cancer cell lines HCC1806 and MDA-MB-231, SRSF3 has been identified as a positive regulator of variant exon inclusion in CD44 pre-mRNA, especially exons v8, v9, and v10 (Guo L. et al., 2022).